cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Aldeyra Therapeutics Inc
12 own
16 watching
Current Price
$4.15
$0.06
(1.47%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
205.88M
52-Week High
52-Week High
8.38000
52-Week Low
52-Week Low
1.42000
Average Volume
Average Volume
0.23M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization205.88M
icon52-Week High8.38000
icon52-Week Low1.42000
iconAverage Volume0.23M
iconDividend Yield--
iconP/E Ratio--
What does the Aldeyra Therapeutics Inc do?
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company s lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma. The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
Read More
How much money does Aldeyra Therapeutics Inc make?
News & Events about Aldeyra Therapeutics Inc.
Globe Newswire
1 year ago
NEW YORK, July 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. ( Aldeyra or the Company ) (NASDAQ: ALDX). Such investors...
Globe Newswire
1 year ago
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. (Aldeyra or the Company) (NASDAQ:ALDX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX PR Newswire NEW YORK, June 23, 2023 NEW YORK, June 23, 2023...
Business Wire
1 year ago
(Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that it will be added to the Russell 2000 and the Russell 3000 indexes, effective after the U.S. equity markets close on June 23...
Business Wire
1 year ago
(Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the 505(b)(2) New Drug Application...
Frequently Asked Questions
Frequently Asked Questions
What is Aldeyra Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Aldeyra Therapeutics Inc shares?
plus_minus_icon
How can I buy Aldeyra Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Aldeyra Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Aldeyra Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Aldeyra Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Aldeyra Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Aldeyra Therapeutics Inc?
plus_minus_icon
What percentage is Aldeyra Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Aldeyra Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.15
$0.06
(1.47%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
PRAXIS PRECISION MEDICINES I
PRAXIS PRECISION MEDICINES I
$57.51
$-0.03 (-0.05 %)
INOZYME PHARMA INC
INOZYME PHARMA INC
$5.82
$0.03 (0.52 %)
GENERATION BIO CO
GENERATION BIO CO
$3.50
$0.08 (2.34 %)
Greenwich LifeSciences Inc
Greenwich LifeSciences Inc
$16.05
$-0.57 (-3.43 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
PRAXIS PRECISION MEDICINES I
PRAXIS PRECISION MEDICINES I
$57.51
$-0.03 (-0.05 %)
INOZYME PHARMA INC
INOZYME PHARMA INC
$5.82
$0.03 (0.52 %)
GENERATION BIO CO
GENERATION BIO CO
$3.50
$0.08 (2.34 %)
Greenwich LifeSciences Inc
Greenwich LifeSciences Inc
$16.05
$-0.57 (-3.43 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00